The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 06-Oct-2023 / 13:34 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 05-Oct-2023 / 13:44 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 04-Oct-2023 / 13:46 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 03-Oct-2023 / 13:28 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 02-Oct-2023 / 14:07 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 29-Sep-2023 / 13:48 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 28-Sep-2023 / 12:51 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 27-Sep-2023 / 12:49 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 26-Sep-2023 / 12:59 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 25-Sep-2023 / 14:17 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 22-Sep-2023 / 12:29 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 21-Sep-2023 / 12:56 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of no...
The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 20-Sep-2023 / 12:51 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of no...
The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 19-Sep-2023 / 14:46 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of no...
The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 18-Sep-2023 / 13:12 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of no...
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 15-Sep-2023 / 13:08 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.